Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia

Aims/hypothesis The aim of this study was to investigate whether dysglycaemia at admission is associated with adverse events at 90 days or 1 year in a population-based cohort of patients hospitalised with community-acquired pneumonia (CAP). Methods Clinical and laboratory data were prospectively col...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetologia 2010-03, Vol.53 (3), p.497-503
Hauptverfasser:	Eurich, D. T, Gamble, J. M, Marrie, T. J, Majumdar, S. R
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Blood Glucose - metabolism Cohort Studies Community-Acquired Infections - therapy Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Follow-Up Studies Hospitalization Human Physiology Humans Internal Medicine Male Medical sciences Medicine Medicine & Public Health Metabolic Diseases Middle Aged Patient Readmission Pneumonia - complications Pneumonia - therapy Proportional Hazards Models Prospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims/hypothesis The aim of this study was to investigate whether dysglycaemia at admission is associated with adverse events at 90 days or 1 year in a population-based cohort of patients hospitalised with community-acquired pneumonia (CAP). Methods Clinical and laboratory data were prospectively collected on all 2,366 adults without diabetes admitted with CAP to six hospitals in Edmonton (AB, Canada) and grouped according to admission glucose: 4.0 to
ISSN:	0012-186X 1432-0428
DOI:	10.1007/s00125-009-1598-y